Skip to content

Hove Pharma

Active
Private limited companyfounded 2019active for 6 yearsKapelstraat 12, 2540 Hove, BelgiumKBO/BCE: BE 0737.798.331

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
24-08
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 24 days late
2025
31-12
Financial Equity above €200,000equity €227,556 ▲19.5%
After 3 profitable years in a row, equity reaches €227,556.
12-08
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 12 days late
2024
23-09
Gazette deed 2 directors appointed, 2 directors resigning
Resignations: Ann Hoeck (director) and Sarah Balduyck (director) · Appointments: JKS Hove BV (director) and APG Management (director) · Permanent representatives: Sarah Balduyck and Ann Hoeck10 points ▸
  • General meeting, 31-07-2024
  • Director resignation, Ann Hoeck (director)
  • Director resignation, Sarah Balduyck (director)
  • Director discharge, Ann Hoeck (director)
  • Director discharge, Sarah Balduyck (director)
  • Other provision, “goedkeuring vergoedingen bestuurders”, 2024 (deed in Dutch)
  • Director appointment, JKS Hove BV (director (not named in the articles))
  • Director appointment, APG Management (director (not named in the articles))
  • Permanent representative, Sarah Balduyck
  • Permanent representative, Ann Hoeck

Open the act in the Belgian Official Gazette

27-08
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 27 days late
2023
31-12
Financial Back to profitnet €22,547
The net result is €22,547, after one loss-making year.
31-12
Financial Equity above €150,000equity €162,157 ▲10.4%
Equity rises from €146,904 to €162,157.
31-08
NBB filing Annual accounts 2022 filedPDF
micro format · 31 days late
2022
31-12
Financial Weakest financial yearnet -€59,044
The net result drops to -€59,044, the lowest from 2020 to 2025. It recovers the following year.
22-08
NBB filing Annual accounts 2021 filedPDF
micro format · 22 days late
2021
31-12
Financial Highest result from 2020 to 2025net €73,218 ▲38.9%
The operating result of €102,439 and the net result of €73,218 are both a record.
31-12
Financial Equity above €200,000equity €205,949 ▲55.2%
With a profit in every financial year since 2020, equity grows to €205,949.
25-08
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 25 days late
2019
20-11
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 18 November 2019, Hove Pharma was incorporated as a private limited company.1 Total assets went from €637,559 in 2020 to €849,286 in 2025 and headcount from 0.5 to 1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020 and 2025

Next steps